Integer (NYSE:ITGR – Free Report) had its target price boosted by Citigroup from $118.00 to $124.00 in a research report report published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the medical equipment provider’s stock. Other equities research analysts have also issued research reports about the stock. Benchmark restated a buy […]